|
| Study ID | Sample size | Cause of pain | RCT design | Intervention | Administration method of the intervention and treatment duration | Control | Pain scale | Assessment time |
|
| [19] | 16 | Stroke or spinal cord injury | Cross-over, 3-week washout | Lidocaine, 5 mg/kg/day | IV; 3 weeks | 0.9% saline | 100-VAS | Until post-infusion |
| [20] | 16 | Stroke or spinal cord injury | Cross-over, 3-week washout | Morphine (9-30 mg/day; mg per day in average) | IV; 3 weeks | 0.9% saline | 100-VAS | Until post-infusion |
| [21] | 20 | Stroke | Cross-over, 2-week washout | Naloxone, 8 mg/session | IV; 2 weeks | 0.9% saline | 100-VAS | Until post-infusion |
| [22] | 42 | Stroke | Cross-over, 2-week washout | Levetiracetam, started at 1000 mg and increased every 2 weeks to 3000 mg | Oral; 8 weeks | Placebo pills | 10-NRS | Post-treatment |
| [12] | 58 | Stroke | Parallel | Prednisolone, 10 mg/day for 2 months | Oral; 4 weeks | No prednisolone | 100-VAS | Post-treatment |
| [23] | 219 | Stroke | Parallel | Pregabalin, 150-600 mg/day | Oral; 12 weeks | Placebo pills | 10-NRS | Post-treatment |
| [24] | 39 | Acute thalamic stroke | Parallel | Amitriptyline, 10-75 mg | Oral; 52 weeks | Placebo pills | NA | Censor point within one year |
| [25] | 15 | Stroke | Cross-over, 1-week washout | Amitriptyline, 12.5-50 mg | Oral; 4 weeks | Carbamazepine (200-800 mg) or placebo pills | 10-step verbal scale | Post-treatment |
| [13] | 26 | Ischemic stroke in MCA territory; ICH stroke in basal ganglia | Parallel | Etanercept, 25 mg | Peri-spinal; 2 weeks | 0.9% saline | 100-VAS or 10-NRS | Post-treatment |
| Vesterguard et al., 2001 [26] | 27 | Stroke | Cross-over, 2-week washout | Lamotrigine, tapered from 25 mg/day to 200 mg/d | Oral; 8 weeks | Placebo pills | 10-NRS | Post-treatment |
| Eun Young et al., 2016 [11] | 21 | First-ever stroke | Parallel | Pamidronate, 60 mg/session, 3 infusions every two days for six days | IV; 2 weeks | Oral prednisolone 1 mg/kg/day | 100-VAS | Post-treatment |
| [27] | 33 | Stroke, spinal cord lesion or other central nervous lesions | Parallel | Ketamine 50-75 mg/session, 5 sessions | Self-powered disposable patch; one week | Placebo patch | 100-VAS | Post-treatment |
| [28] | 40 | Stroke, spinal cord lesion or other central nervous lesions | Parallel | Pregabalin, 150-600 mg/day, 4 weeks | Oral; 4 weeks | Placebo pills | 100-VAS | Post-treatment |
|